Johan W. Mouton

International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti‐infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)

Brian T. Tsuji, Jason M. Pogue, Alexandre Prehn Zavascki et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2019 · 931 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +17

Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial

Mical Paul, George L. Daikos, Emanuele Durante‐Mangoni et al. · The Lancet Infectious Diseases · 2018 · 624 citations

Life Sciences, Infectious Diseases, Microbiology +14

Nasal Carriage Of Staphylococcus aureus As A Major Risk Factor For Wound Infections After Cardiac Surgery

Jan Kluytmans, Johan W. Mouton, E. P. F. IJzerman et al. · The Journal of Infectious Diseases · 1995 · 435 citations

Veterinary Medicine, Infectious Diseases, Surgery +17

Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus

Roger L. Nation, Jian Li, Otto Cars et al. · The Lancet Infectious Diseases · 2014 · 343 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacotherapy +15

MIC-based dose adjustment: facts and fables

Johan W. Mouton, Anouk E. Muller, Rafael Cantón et al. · Journal of Antimicrobial Chemotherapy · 2017 · 327 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17